Targeting endothelial thioredoxin-interacting protein (TXNIP) protects from metabolic disorder-related impairment of vascular function and post-ischemic revascularisation

被引：0

作者：

Alison Domingues

Catherine Boisson-Vidal

Perrine Marquet de Rouge

Blandine Dizier

Jérémy Sadoine

Virginie Mignon

Emilie Vessières

Daniel Henrion

Virginie Escriou

Pascal Bigey

Catherine Chaussain

David M. Smadja

Valérie Nivet-Antoine

机构：

[1] Université de Paris,INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy

[2] Université de Paris,EA 2496, Laboratory of Orofacial Pathologies, Imaging and Biotherapies, Dental School

[3] Université de Paris,PTICM, CNRS, INSERM 3612

[4] Université Angers,CNRS, INSERM 1083, MITOVASC

[5] Université de Paris,CNRS, Unité de Technologies Chimiques et Biologiques pour la santé (UTCBS), UMR 8258, INSERM 1022

[6] AP-HP,Odontology Department

[7] Bretonneau Hospital,Service d’Hématologie et Laboratoire de Recherches Biochirugicales (Fondation Carpentier)

[8] AH-HP,Clinical Biochemistry Department

[9] Georges Pompidou European Hospital,undefined

[10] AP-HP,undefined

[11] Necker Hospital,undefined

来源：

Angiogenesis | 2020年 / 23卷

关键词：

TXNIP; Metabolic disorders; Endothelial dysfunction; Oxidative stress; Arterial damage; Post-ischemic revascularisation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：249 / 264

页数：15

共 2 条